Skip to main navigation Skip to search Skip to main content

Spotted fever group rickettsioses in Israel, 2010–2019

  • Regev Cohen
  • , Talya Finn
  • , Frida Babushkin
  • , Yael Paran
  • , Ronen Ben Ami
  • , Alaa Atamna
  • , Sharon Reisfeld
  • , Gabriel Weber
  • , Neta Petersiel
  • , Hiba Zayyad
  • , Eyal Leshem
  • , Miriam Weinberger
  • , Yasmin Maor
  • , Nicola Makhoul
  • , Lior Nesher
  • , Galia Zaide
  • , Dar Klein
  • , Adi Beth-Din
  • , Yafit Atiya-Nasagi
  • Sanz Medical Center-Laniado Hospital Israel
  • Technion-Israel Institute of Technology
  • Tel Aviv Sourasky Medical Center
  • Tel Aviv University
  • Rabin Medical Center Israel
  • Hille Yaffe Medical Center Israel
  • Carmel Medical Centre
  • Rambam Health Care Campus Israel
  • Poriya Medical Centre
  • Sheba Medical Center at Tel Hashomer
  • Assaf Harofeh Medical Center
  • Edith Wolfson Medical Center Israel
  • Galilee Medical Centre
  • Soroka Medical Center
  • Ben-Gurion University of the Negev
  • Israel Institute for Biological Research

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

In a multicenter, nationwide, retrospective study of patients hospitalized with spotted fever group rickettsiosis in Israel during 2010–2019, we identified 42 cases, of which 36 were autochthonous. The most prevalent species was the Rickettsia conorii Israeli tick typhus strain (n = 33, 79%); infection with this species necessitated intensive care for 52% of patients and was associated with a 30% fatality rate. A history of tick bite was rare, found for only 5% of patients; eschar was found in 12%; and leukocytosis was more common than leukopenia. Most (72%) patients resided along the Mediterranean shoreline. For 3 patients, a new Rickettsia variant was identified and had been acquired in eastern, mountainous parts of Israel. One patient had prolonged fever before admission and clinical signs resembling tickborne lymphadenopathy. Our findings suggest that a broad range of Rickettsia species cause spotted fever group rickettsiosis in Israel.

Original languageEnglish
Pages (from-to)2117-2126
Number of pages10
JournalEmerging Infectious Diseases
Volume27
Issue number8
DOIs
StatePublished - Aug 2021

Bibliographical note

Publisher Copyright:
© 2021 Centers for Disease Control and Prevention (CDC). All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Spotted fever group rickettsioses in Israel, 2010–2019'. Together they form a unique fingerprint.

Cite this